111 related articles for article (PubMed ID: 37930047)
1. The value of Demetics ultrasound-assisted diagnosis system in diagnosis of breast lesions and in assessment Ki-67 status of breast cancer.
Wang Y; Nie F; Liu T; Zhu Y; Jia Y; Li N; Wu R
J Clin Ultrasound; 2024 Feb; 52(2):112-123. PubMed ID: 37930047
[TBL] [Abstract][Full Text] [Related]
2. The value of the Demetics ultrasound-assisted diagnosis system in the differential diagnosis of benign from malignant thyroid nodules and analysis of the influencing factors.
Mai W; Zhou M; Li J; Yi W; Li S; Hu Y; Ji J; Zeng W; Gao B; Liu H
Eur Radiol; 2021 Oct; 31(10):7936-7944. PubMed ID: 33856523
[TBL] [Abstract][Full Text] [Related]
3. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of thyroid nodules by the Demetics ultrasound-assisted diagnosis system and contrast-enhanced ultrasound combined with thyroid image reporting and data systems.
Wang G; Nie F; Wang Y; Yang D; Dong T; Liu T; Wang P
Clin Endocrinol (Oxf); 2022 Jul; 97(1):116-123. PubMed ID: 35441715
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning-Based Computer-Aided Diagnosis for Breast Lesion Classification on Ultrasound: A Prospective Multicenter Study of Radiologists Without Breast Ultrasound Expertise.
He P; Chen W; Bai MY; Li J; Wang QQ; Fan LH; Zheng J; Liu CT; Zhang XR; Yuan XR; Song PJ; Cui LG
AJR Am J Roentgenol; 2023 Oct; 221(4):450-459. PubMed ID: 37222275
[No Abstract] [Full Text] [Related]
6. Computer-aided classification of BI-RADS category 3 breast lesions.
Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
[TBL] [Abstract][Full Text] [Related]
7. Combined diagnosis of multiparametric MRI-based deep learning models facilitates differentiating triple-negative breast cancer from fibroadenoma magnetic resonance BI-RADS 4 lesions.
Yin HL; Jiang Y; Xu Z; Jia HH; Lin GW
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2575-2584. PubMed ID: 35771263
[TBL] [Abstract][Full Text] [Related]
8. Reducing the number of unnecessary biopsies of US-BI-RADS 4a lesions through a deep learning method for residents-in-training: a cross-sectional study.
Zhao C; Xiao M; Liu H; Wang M; Wang H; Zhang J; Jiang Y; Zhu Q
BMJ Open; 2020 Jun; 10(6):e035757. PubMed ID: 32513885
[TBL] [Abstract][Full Text] [Related]
9. What Help Could Ultrasound Elastography Give to the Diagnosis of Breast Papillary Lesions?
Li LJ; Yao JY; Zhou XC; Zhao XB; Zhong WJ; Ou B; Luo BM; Hao SY; Zhi H
Ultrasound Med Biol; 2017 May; 43(5):903-910. PubMed ID: 28256344
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of B-mode ultrasound Breast Imaging Reporting and Data System category 3-4a lesions in conjunction with shear-wave elastography using conservative and aggressive approaches.
Zhi W; Miao A; You C; Zhou J; Zhang H; Zhu X; Wang Y; Chang C
Quant Imaging Med Surg; 2022 Jul; 12(7):3833-3843. PubMed ID: 35782244
[TBL] [Abstract][Full Text] [Related]
11. A deep learning model integrating mammography and clinical factors facilitates the malignancy prediction of BI-RADS 4 microcalcifications in breast cancer screening.
Liu H; Chen Y; Zhang Y; Wang L; Luo R; Wu H; Wu C; Zhang H; Tan W; Yin H; Wang D
Eur Radiol; 2021 Aug; 31(8):5902-5912. PubMed ID: 33496829
[TBL] [Abstract][Full Text] [Related]
12. Artificial Intelligence in BI-RADS Categorization of Breast Lesions on Ultrasound: Can We Omit Excessive Follow-ups and Biopsies?
Guldogan N; Taskin F; Icten GE; Yilmaz E; Turk EB; Erdemli S; Parlakkilic UT; Turkoglu O; Aribal E
Acad Radiol; 2023 Dec; ():. PubMed ID: 38087719
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of acoustic radiation force impulse for BI-RADS category 4 breast lesions of different sizes.
You QQ; Xu M; Yao MH; Xu G; Liu H; Pu H; Xiang LH; Wu R
Clin Hemorheol Microcirc; 2018; 70(2):143-154. PubMed ID: 29710678
[TBL] [Abstract][Full Text] [Related]
14. Gail Model Improves the Diagnostic Performance of the Fifth Edition of Ultrasound BI-RADS for Predicting Breast Cancer: A Multicenter Prospective Study.
Gao LY; Gu Y; Tian JW; Ran HT; Ren WD; Chang C; Yuan JJ; Kang CS; Deng YB; Luo BM; Zhou Q; Zhan WW; Zhou Q; Li J; Zhou P; Zhang CQ; Chen M; Gu Y; Guo JF; Chen W; Zhang YH; Li JC; Wang HY; Jiang YX
Acad Radiol; 2022 Jan; 29 Suppl 1():S1-S7. PubMed ID: 33384211
[TBL] [Abstract][Full Text] [Related]
15. Value of inversion imaging to diagnosis in differentiating malignant from benign breast masses.
Li N; Hou Z; Wang J; Bi Y; Wu X; Zhan Y; Peng M
BMC Med Imaging; 2023 Dec; 23(1):206. PubMed ID: 38066441
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Value of 3D Power Doppler Ultrasound Combined With VOCAL in the Vascular Distribution of Breast Masses.
Wang H; Yan B; Yue L; He M; Liu Y; Li H
Acad Radiol; 2020 Feb; 27(2):198-203. PubMed ID: 31053481
[TBL] [Abstract][Full Text] [Related]
17. An artificial intelligence system using maximum intensity projection MR images facilitates classification of non-mass enhancement breast lesions.
Wang L; Chang L; Luo R; Cui X; Liu H; Wu H; Chen Y; Zhang Y; Wu C; Li F; Liu H; Guan W; Wang D
Eur Radiol; 2022 Jul; 32(7):4857-4867. PubMed ID: 35258676
[TBL] [Abstract][Full Text] [Related]
18. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
[TBL] [Abstract][Full Text] [Related]
19. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
Du YR; Wu Y; Chen M; Gu XG
Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
[TBL] [Abstract][Full Text] [Related]
20. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
